JP2015533821A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533821A5
JP2015533821A5 JP2015534660A JP2015534660A JP2015533821A5 JP 2015533821 A5 JP2015533821 A5 JP 2015533821A5 JP 2015534660 A JP2015534660 A JP 2015534660A JP 2015534660 A JP2015534660 A JP 2015534660A JP 2015533821 A5 JP2015533821 A5 JP 2015533821A5
Authority
JP
Japan
Prior art keywords
peptide
pharmaceutical formulation
isolated peptide
pharmaceutical
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015534660A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533821A (ja
Filing date
Publication date
Priority claimed from US13/662,245 external-priority patent/US9511110B2/en
Priority claimed from US13/662,253 external-priority patent/US9133440B2/en
Priority claimed from US13/662,232 external-priority patent/US20140120560A1/en
Priority claimed from US13/662,209 external-priority patent/US8911776B2/en
Application filed filed Critical
Priority claimed from PCT/US2013/061947 external-priority patent/WO2014052611A1/en
Publication of JP2015533821A publication Critical patent/JP2015533821A/ja
Publication of JP2015533821A5 publication Critical patent/JP2015533821A5/ja
Pending legal-status Critical Current

Links

JP2015534660A 2012-09-27 2013-09-26 新たな膵臓ベータ細胞の生成 Pending JP2015533821A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201261706225P 2012-09-27 2012-09-27
US61/706,225 2012-09-27
US13/662,232 2012-10-26
US13/662,253 2012-10-26
US13/662,245 US9511110B2 (en) 2012-09-27 2012-10-26 Generation of new pancreatic beta cells
US13/662,253 US9133440B2 (en) 2012-09-27 2012-10-26 Generation of new pancreatic beta cells
US13/662,232 US20140120560A1 (en) 2012-10-26 2012-10-26 Generation of new pancreatic beta cells
US13/662,209 2012-10-26
US13/662,209 US8911776B2 (en) 2012-09-27 2012-10-26 Generation of new pancreatic beta cells
US13/662,245 2012-10-26
PCT/US2013/061947 WO2014052611A1 (en) 2012-09-27 2013-09-26 Generation of new pancreatic beta cells

Publications (2)

Publication Number Publication Date
JP2015533821A JP2015533821A (ja) 2015-11-26
JP2015533821A5 true JP2015533821A5 (https=) 2016-11-10

Family

ID=50388965

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015534660A Pending JP2015533821A (ja) 2012-09-27 2013-09-26 新たな膵臓ベータ細胞の生成

Country Status (5)

Country Link
EP (1) EP2900691A4 (https=)
JP (1) JP2015533821A (https=)
AU (1) AU2013323462A1 (https=)
CA (1) CA2886442A1 (https=)
WO (1) WO2014052611A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104614523B (zh) * 2014-12-19 2016-09-21 成都永安制药有限公司 结核分枝杆菌tb-sa抗体酶联免疫法检测试剂盒及其制备方法
WO2017063657A1 (en) * 2015-10-14 2017-04-20 Phlogo Aps Il1ra-derived peptide antagonist
US20190142901A1 (en) * 2017-11-16 2019-05-16 Claresa Levetan Compositions and methods for treating or preventing type 1 diabetes using a biologic response modifier in combination with one or more islet or beta cell regeneration or replacement therapies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
CA2343656A1 (en) * 1998-09-17 2000-04-06 The Trustees Of Columbia University In The City Of New York Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
US20040132644A1 (en) * 2001-10-16 2004-07-08 The Procter & Gamble Company Composition and method for treating diabetes
EP1883417A2 (en) * 2005-05-25 2008-02-06 Curedm Inc. Peptides, derivatives and analogs thereof, and methods of using same
EA201000399A1 (ru) * 2007-08-30 2011-02-28 Кьюрдм, Инк. Композиции и способы использования проостровковых пептидов и их аналогов
US20110082080A1 (en) * 2007-10-12 2011-04-07 Curedm Group Holdings, Llc Compositions and methods of using the human proislet peptide receptor

Similar Documents

Publication Publication Date Title
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
IL262805B2 (en) Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
JP2010500399A5 (https=)
JP2014521684A5 (https=)
HRP20220717T1 (hr) Modificirani pripravci mrna
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
RU2011110504A (ru) Эпитопные пептиды inhbb и вакцины, содержащие данные пептиды
CA2961029A1 (en) Peptidomimetic macrocycles and formulations thereof
NZ601818A (en) Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers
JP2015522573A5 (https=)
NZ552558A (en) Compositions for delivering peptide YY and PYY agonists
JP2017523985A5 (https=)
JP2012505922A5 (https=)
JP2019533722A5 (https=)
JP2014050390A5 (https=)
HRP20231652T1 (hr) Peptidi za primjenu u liječenju oralnog mukozitisa
JP2015533821A5 (https=)
EP4294454B1 (en) Anti-viral peptides and compositions and methods of use thereof
JP2013542196A5 (https=)
WO2007061829A3 (en) Pharmaceutical composition
JP2020515283A5 (https=)
TW201815410A (zh) 藥物之經黏膜吸收促進劑
HK1203157A1 (en) Sustained delivery of molecules using peptide surfactants and uses thereof
JP2015514771A5 (https=)
JP2016535015A5 (https=)